UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Volltextzugriff (PDF)

Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies

Scientific reports, 2023-04, Vol.13 (1), p.6730-6730, Article 6730

2023

Volltextzugriff (PDF)

In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories

Antimicrobial agents and chemotherapy, 2018-10, Vol.62 (10)

2018

Volltextzugriff (PDF)

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

Clinical infectious diseases, 2016-08, Vol.63 (3), p.356-362

2016

Volltextzugriff (PDF)

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response

Clinical infectious diseases, 2017-06, Vol.64 (11), p.1557-1563

2017

Volltextzugriff (PDF)

Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial

Vaccine, 2024-04, Vol.42 (10), p.2560-2571

2024

Volltextzugriff (PDF)

Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)

Antimicrobial agents and chemotherapy, 2016-08, Vol.60 (8), p.4568-4576

2016

Volltextzugriff (PDF)

Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis

Antimicrobial agents and chemotherapy, 2021-05, Vol.65 (6)

2021

Volltextzugriff (PDF)

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2113-2121

2011

Volltextzugriff (PDF)

Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Antimicrobial agents and chemotherapy, 2021-07, Vol.65 (8), p.e0029021

2021

Volltextzugriff (PDF)

Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1885-1891

2016

Volltextzugriff (PDF)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis

The Pediatric infectious disease journal, 2018-10, Vol.37 (10), p.992-998

2018

Volltextzugriff (PDF)

Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy Subjects

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6)

2019

Volltextzugriff (PDF)

Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole

Antimicrobial agents and chemotherapy, 2017-06, Vol.61 (6)

2017

Volltextzugriff (PDF)

Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis

Antimicrobial agents and chemotherapy, 2016-05, Vol.60 (5), p.2718-2726

2016

Volltextzugriff (PDF)

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

Antimicrobial agents and chemotherapy, 2019-01, Vol.63 (1)

2019

Volltextzugriff (PDF)

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis

Antimicrobial agents and chemotherapy, 2019-09, Vol.63 (9)

2019

Volltextzugriff (PDF)

Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis

Journal of Pharmacokinetics and Pharmacodynamics, 2017-04, Vol.44 (2), p.143-151

2017

Volltextzugriff (PDF)

Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5714-5716

2013

Volltextzugriff (PDF)

In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds

Antimicrobial agents and chemotherapy, 2014-11, Vol.58 (11), p.6934-6937

2014

Volltextzugriff (PDF)

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents

Antimicrobial agents and chemotherapy, 2015-02, Vol.59 (2), p.905-913

2015

Volltextzugriff (PDF)

Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Volltextzugriff (PDF)

Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis

Expert review of clinical pharmacology, 2016-07, Vol.9 (7), p.887-897

2016

Volltextzugriff (PDF)

Pharmacokinetics of an elevated dosage of micafungin in premature neonates

The Pediatric infectious disease journal, 2009-05, Vol.28 (5), p.412-415

2009

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(58)
Dissertationen
(1)

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Humans
(31)
Microbiology
(29)
Pharmacology & Pharmacy
(28)
Antifungal Agents
(21)
Female
(19)
Antifungal Agents - Therapeutic Use
(17)
Infectious Diseases
(16)
Male
(16)
Isavuconazole
(15)
Nitriles
(15)
Pyridines
(15)
Triazoles
(15)
Antifungal Agents - Pharmacokinetics
(14)
Immunology
(14)
Nitriles - Therapeutic Use
(13)
Triazoles - Therapeutic Use
(13)
Microbial Sensitivity Tests
(12)
Pyridines - Therapeutic Use
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies

In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response

Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial

Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)

Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis

Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy Subjects

Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole

Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis

Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis

Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization

In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents

Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis

Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis

Pharmacokinetics of an elevated dosage of micafungin in premature neonates

Suchergebnisse filtern